www.transfusion.ru
О Службе крови России
Скажем донору спасибо
Совет служб крови СНГ
Документы
Технологический форум
Журналы и статьи
Федеральная программа
Региональные программы
Фирмы предлагают
Видео
Хроника событий
РАТ
Новости РАТ
Вам отвечают специалисты
Контакты/Ссылки
Поиск
Наш сайт
English
Документы

Haemonetics handed $15M in patent ruling

Braintree-based Haemonetics Corp., a provider of blood management products, has won a $15.7 million settlement for alleged patent infringement.

This week, a federal court ordered Fenwal Inc., a transfusion products provider based in Illinois, to make the payment to Haemonetics (NYSE: HAE). The judgment followed seven days of trial and two days of deliberation by the jury, stated law firm Sherin and Lodgen LLP, which represented Haemonetics. The trial was held in the U.S. District Court for Massachusetts. Fenwal’s blood collecting device was found to be in violation of Haemonetics’ patent for an automated blood collection system.

Thursday, February 5, 2009

The Journal of New England Technology